1-8 of 8
Remy Castellano
Close
Sort by
Journal Articles

DIACC2010, Sole-in-Class Selective Inhibitor of Kinesin KIF20A, Has Potent Preclinical Efficacy in Acute Myeloid Leukemia

Sylvain Garciaz, Yves Collette, Remy Castellano, Michel Aurrand-Lions, Helene Sicard, Laetitia Jentreau, Norbert Vey, Cecile Bougeret
Journal: Blood
Blood (2022) 140 (Supplement 1): 7800–7801.
https://doi.org/10.1182/blood-2022-166820
Published: 2022
Journal Articles

Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome

Florent Amatore, Mathilde Barré, Florence Orlanducci, Marc Lopez, Remy Castellano, Caroline Ram-Wolff, Laurent Gorvel, Armelle Goubard, Caroline Gaudy-Marqueste, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive
Journal: Blood
Blood (2021) 138 (Supplement 1): 2260.
https://doi.org/10.1182/blood-2021-153345
Published: 2021
Journal Articles

ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells

Florent Amatore, Nicolas Ortonne, Marc Lopez, Mathilde Barré, Florence Orlanducci, Remy Castellano, Saskia Ingen-Housz-Oro, Amandine De Croos, Laurent Gorvel, Armelle Goubard, Reda Bouabdallah, Jean Marc Schiano De Colella, Jean-Jacques Grob, Philippe Gaulard, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive
Journal: Blood
Blood (2021) 138 (Supplement 1): 790.
https://doi.org/10.1182/blood-2021-150677
Published: 2021
Journal Articles

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Julie Agopian, Quentin Da Costa, Quang Vo Nguyen, Giulia Scorrano, Paraskevi Kousteridou, Min Yuan, Rabie Chelbi, Armelle Goubard, Remy Castellano, Julien Maurizio, Cristina Teodosio, Paulo De Sepulveda, John M. Asara, Alberto Orfao, Olivier Hermine, Patrice Dubreuil, Fabienne Brenet
Journal: Blood
Blood (2021) 138 (17): 1590–1602.
https://doi.org/10.1182/blood.2020008948
Published: 2021
Includes: Supplemental data
Journal Articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey, MD PhD, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, Aude Charbonnier, Bilal Mohty, MD, Evelyne D'Incan, Jerome Rey, Remy Castellano, Camille Montersino, Max Chaffanet, Nadine Carbuccia, Jose Adelaide, Benjamin Bouchacourt, Arnaud Guille
Journal: Blood
Blood (2018) 132 (Supplement 1): 1401.
https://doi.org/10.1182/blood-2018-99-119263
Published: 2018
Journal Articles

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy

Ruxanda Moschoi, Véronique Imbert, Marielle Nebout, Johanna Chiche, Didier Mary, Thomas Prebet, Estelle Saland, Rémy Castellano, Laurent Pouyet, Yves Collette, Norbert Vey, Christian Chabannon, Christian Recher, Jean-Emmanuel Sarry, Damien Alcor, Jean-François Peyron, Emmanuel Griessinger
Journal: Blood
Blood (2016) 128 (2): 253–264.
https://doi.org/10.1182/blood-2015-07-655860
Published: 2016
Includes: Supplemental data
Journal Articles

Vgamma9Vdelta2 T Cells-Based Immunotherapy Targeting BTN3 Molecules in Acute Myeloid Leukemia

Daniel Olive, MD, PhD, Audrey Benyamine, MD, Aude Le Roy, Rémy Castellano, PhD, Julie Gertner-Dardenne, Norbert Vey, MDPhD
Journal: Blood
Blood (2014) 124 (21): 3726.
https://doi.org/10.1182/blood.V124.21.3726.3726
Published: 2014
Journal Articles

Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.

Hassiba Chaib, BSc, Thomas Prebet, MD, Audrey Restouin, BSc, Remy Castellano, PhD, Sandrine Opi, PhD, Daniel Olive, MD, PhD, Jean Paul Borg, PD, PhD, Norbert Vey, MD, Yves Collette, PhD
Journal: Blood
Blood (2007) 110 (11): 889.
https://doi.org/10.1182/blood.V110.11.889.889
Published: 2007